AU7397887A - Lipopolysaccharide and natural factor compositions for anti-tumor therapy and method of treatment - Google Patents

Lipopolysaccharide and natural factor compositions for anti-tumor therapy and method of treatment

Info

Publication number
AU7397887A
AU7397887A AU73978/87A AU7397887A AU7397887A AU 7397887 A AU7397887 A AU 7397887A AU 73978/87 A AU73978/87 A AU 73978/87A AU 7397887 A AU7397887 A AU 7397887A AU 7397887 A AU7397887 A AU 7397887A
Authority
AU
Australia
Prior art keywords
lipopolysaccharide
treatment
tumor therapy
natural factor
factor compositions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU73978/87A
Inventor
Myung Chun
Ulrich Hammerling
Michael K. Hoffmann
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sloan Kettering Institute for Cancer Research
Original Assignee
Sloan Kettering Institute for Cancer Research
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sloan Kettering Institute for Cancer Research filed Critical Sloan Kettering Institute for Cancer Research
Publication of AU7397887A publication Critical patent/AU7397887A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/191—Tumor necrosis factors [TNF], e.g. lymphotoxin [LT], i.e. TNF-beta
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A61K31/405—Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/675—Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/195—Chemokines, e.g. RANTES
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/20—Interleukins [IL]
    • A61K38/2006—IL-1
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/20—Interleukins [IL]
    • A61K38/2013—IL-2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU73978/87A 1986-05-09 1987-05-07 Lipopolysaccharide and natural factor compositions for anti-tumor therapy and method of treatment Abandoned AU7397887A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US86156686A 1986-05-09 1986-05-09
US861566 1986-05-09

Publications (1)

Publication Number Publication Date
AU7397887A true AU7397887A (en) 1987-12-01

Family

ID=25336155

Family Applications (1)

Application Number Title Priority Date Filing Date
AU73978/87A Abandoned AU7397887A (en) 1986-05-09 1987-05-07 Lipopolysaccharide and natural factor compositions for anti-tumor therapy and method of treatment

Country Status (4)

Country Link
EP (1) EP0271521A4 (en)
JP (1) JPS63503308A (en)
AU (1) AU7397887A (en)
WO (1) WO1987006830A1 (en)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4844895A (en) * 1985-11-01 1989-07-04 New York University Composition containing a peptide fragment of platelet factor four and method for restoring suppressed immune responses
ATE91237T1 (en) * 1986-10-16 1993-07-15 Harvard College COMBINATIONS OF NECROSIS-TUMORS FACTORS AND ANTI-INFLAMMATORY AGENTS FOR THE TREATMENT OF MALIGNANT AND NON-MALIGNANT DISEASES.
WO2002034119A2 (en) 2000-10-27 2002-05-02 Immuno-Rx, Inc. Vaccine immunotherapy for immune suppressed patients
US20070025958A1 (en) 2000-10-27 2007-02-01 Hadden John W Vaccine immunotherapy
TW200303759A (en) * 2001-11-27 2003-09-16 Schering Corp Methods for treating cancer
AU2002364051A1 (en) * 2002-01-24 2003-09-02 Children's Medical Center Corporation Anti-cancer combination and use thereof
ES2263859T3 (en) 2003-02-18 2006-12-16 Clinique La Prairie Research Sa COMPOSITIONS QU4E INCLUDE FETAL HEMOGLOBIN AND BACTERIAL ENDOTOXIN AND OPTIONALLY ADDITIONAL FETAL LIVER COMPONENTS.
US20050059613A1 (en) * 2003-07-08 2005-03-17 Bahram Memarzadeh Compositions and methods for the enhanced uptake of therapeutic agents through the bladder epithelium
EP1881080A1 (en) * 2006-07-18 2008-01-23 Institut Gustave Roussy Toll like receptor 4 dysfunction and the biological applications thereof
EP2234642B8 (en) 2007-11-28 2017-11-01 IRX Therapeutics, Inc. Method of increasing immunological effect
ES2679043T3 (en) 2009-05-15 2018-08-21 Irx Therapeutics, Inc. Vaccine immunotherapy
CN107050430B (en) 2009-12-08 2021-10-15 伊尔克斯治疗有限公司 Method for reversing Langerhans cell immunosuppression

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH643138A5 (en) * 1983-08-29 1984-05-30 Mepha Ag INDOMETHACIN CONTAINING, gelatinous OINTMENT.

Also Published As

Publication number Publication date
EP0271521A4 (en) 1989-11-14
EP0271521A1 (en) 1988-06-22
WO1987006830A1 (en) 1987-11-19
JPS63503308A (en) 1988-12-02

Similar Documents

Publication Publication Date Title
AU1897088A (en) Method of treating patients suffering from chronic pain or chronic cough
AU7211787A (en) Intraocular dosage compositions and method of use
AU7524287A (en) Method of surface treatment and apparatus used therefor
AU1520188A (en) Compositions and methods of treatment of timber
AU7026587A (en) Irradiator and method of using an irradiator to irradiate
AU6979487A (en) Treatment of gases
AU7397887A (en) Lipopolysaccharide and natural factor compositions for anti-tumor therapy and method of treatment
AU8013587A (en) A method and composition for the treatment of bathtubs
AU6812387A (en) Method of inducing an immunosuppressant effect using sulphamoylamino-ergo lines
AU1273488A (en) Apparatus and method of creating and controlling an artificial water table
AU629103C (en) Vaccine and method of preparation
BG41842A1 (en) Method for simultaneous treatment of femuro- thibial and femuro- patelaric artrose
AU7113191A (en) Vaccine and method of preparation
ZA888338B (en) Pharmaceutical compositions and method of treatment
GB8812228D0 (en) Method of treatment
GB8819544D0 (en) Method of treatment
GB8808914D0 (en) Method of treatment
GB8808915D0 (en) Method of treatment
GB8811006D0 (en) Method of treatment
GB8811891D0 (en) Method of treatment
GB8812224D0 (en) Method of treatment
GB8812225D0 (en) Method of treatment
GB8812226D0 (en) Method of treatment
GB8812227D0 (en) Method of treatment
GB8804204D0 (en) Method of treatment